^
Association details:
| Biomarker: | HR positive |
|---|---|
| Cancer: | HER2 Positive Breast Cancer |
| Drug Class: | HER2 inhibitor + Aromatase inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer
Excerpt:
Targeted Therapy: The addition of HER2-targeted therapy to first-line AIs should be offered to patients with HR-positive, HER2-positive MBC in whom chemotherapy is not immediately indicated.
DOI:
10.1200/JCO.2016.67.1487
